Drugs / Kovanaze
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | KOVANAZE | — | 2016-06-29 | fda.gov ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04105985 | Aug 2020 → Aug 2021 | dental caries, periapical periodontitis | Virginia Commonwealth University | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Kovanaze | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04105985 ↗ |